Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Luger

Showing results (291-300 of 677) with videos related to

Pageof 68
Sort By:
Diabetologia|September 17, 2009
Beta cell (dys)function in non-diabetic offspring of diabetic patientsM Stadler, G Pacini, J Petrie, et al.
Archiv Fur Dermatologische Forschung|January 1, 1972
[Andrologic studies in high-dose vitamin A therapy]G Gasser, A Luger, H Ita, et al.
The Journal of Experimental Medicine|February 1, 1986
Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1A Köck, M Danner, B M Stadler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivityS Grabbe, K Steinbrink, M Steinert, et al.
Medicine|July 1, 1981
Hypertension in pregnancy: clinical-pathological correlations and remote prognosisK A Fisher, A Luger, B H Spargo, et al.
Journal of the American Academy of Dermatology|February 1, 1997
Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2aB Kütting, G Bonsmann, D Metze, et al.
Experimental Dermatology|December 1, 1994
Regulation of monocyte and keratinocyte interleukin 6 production by transforming growth factor betaA Möller, A Schwarz, P Neuner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 17, 2005
Case mix measures and diagnosis-related groups: opportunities and threats for inpatient dermatologyP Hensen, T Fürstenberg, T A Luger, et al.
Clinical and Experimental Rheumatology|February 10, 2006
New insight into immunosuppression and treatment of autoimmune diseasesM Böhm, T A Luger, M Schneider, et al.
The British Journal of Dermatology|March 29, 2007
Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skinS Ständer, H Ständer, S Seeliger, et al.
Pageof 68

Showing results (291-300 of 677) with videos related to

Sort By:
Pageof 68
Diabetologia|September 17, 2009
Beta cell (dys)function in non-diabetic offspring of diabetic patientsM Stadler, G Pacini, J Petrie, et al.
Archiv Fur Dermatologische Forschung|January 1, 1972
[Andrologic studies in high-dose vitamin A therapy]G Gasser, A Luger, H Ita, et al.
The Journal of Experimental Medicine|February 1, 1986
Characterization of a monoclonal antibody directed against the biologically active site of human interleukin 1A Köck, M Danner, B M Stadler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1995
Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivityS Grabbe, K Steinbrink, M Steinert, et al.
Medicine|July 1, 1981
Hypertension in pregnancy: clinical-pathological correlations and remote prognosisK A Fisher, A Luger, B H Spargo, et al.
Journal of the American Academy of Dermatology|February 1, 1997
Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2aB Kütting, G Bonsmann, D Metze, et al.
Experimental Dermatology|December 1, 1994
Regulation of monocyte and keratinocyte interleukin 6 production by transforming growth factor betaA Möller, A Schwarz, P Neuner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 17, 2005
Case mix measures and diagnosis-related groups: opportunities and threats for inpatient dermatologyP Hensen, T Fürstenberg, T A Luger, et al.
Clinical and Experimental Rheumatology|February 10, 2006
New insight into immunosuppression and treatment of autoimmune diseasesM Böhm, T A Luger, M Schneider, et al.
The British Journal of Dermatology|March 29, 2007
Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skinS Ständer, H Ständer, S Seeliger, et al.
Pageof 68